After a gap-up, Enzolytics Inc (OTCMKTS:ENZC) is seeing profit taking in late afternoon trading.
As of 3:02, ENZC stock is trading higher by 8.31% to $0.1341. So far more than 47.98 million shares have traded, above its 30-day average volume of 40.16 million shares. The stock opened at $0.1540 and moved within a narrow range of $0.1303-$0.1600.
ENZC Co Authors White Paper
Enzolytics Inc. and Intel Corporation Co-Author White Paper on Use of Artificial Intelligence for Social Good
- In a significant white paper, Enzolytics inc. (OTC PINK:ENZC) (http://enzolytics.com/) and Intel Corporation (https://www.intel.com) has published a thought leadership collaboration.
- The white paper titled, “Optimizing Empathetic A.I. to Cure Deadly Diseases,”
- highlights Intel’s Artificial Intelligence Analytic tools and Enzolytic’s innovative approach and groundbreaking contributions to create universal, durable, and broadly effective treatment targeting all virus variants.
- This collaborative effort approaches the future of medicine; a future wherein the process of healthcare evolves from reactive to anticipatory, as exemplified by P4 Medicine, a term coined by Biologist Leroy Hood
|SHARES OUTSTANDING||2,797.94 M|
|SHARE FLOAT (%)||105.84 M (3.78%)|
|% HELD BY INSTITUTIONS||0.03|
Recent Stock Performance
|+/- EMA(20)||0.14 (-7.14%)|
|+/- SMA(50)||0.20 (-35.00%)|
|+/- SMA(200)||0.14 (-7.14%)|
|CCI20||-61.1947||Sell||Chaikin Money Flow||0.0471||Neutral|
|MACD||-0.0478||Sell||Money Flow Index||47.7722||Sell|
|STOCH (14,3)||44.5469||Neutral||STOCH RSI||1.0000||OverBought|